| scholarly article | Q13442814 |
| P50 | author | May Morris | Q43178782 |
| Laurent Chaloin | Q46022210 | ||
| P2093 | author name string | R S Goody | |
| F Heitz | |||
| C Devaux | |||
| G Divita | |||
| V Robert-Hebmann | |||
| M C Morris | |||
| J Mery | |||
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1 | Q27729415 | ||
| High resolution structures of HIV-1 RT from four RT-inhibitor complexes | Q27729427 | ||
| Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors | Q27729428 | ||
| Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance | Q27766086 | ||
| Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor | Q29547710 | ||
| Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA | Q29620616 | ||
| Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. | Q34382153 | ||
| Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer | Q35623899 | ||
| Conformational stability of dimeric HIV-1 and HIV-2 reverse transcriptases | Q38287870 | ||
| Dimerization kinetics of HIV-1 and HIV-2 reverse transcriptase: a two step process | Q38298949 | ||
| A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. | Q38344289 | ||
| Structural mechanisms of HIV drug resistance | Q41048246 | ||
| Chemical crosslinking of the subunits of HIV-1 reverse transcriptase. | Q42740741 | ||
| Protein-protein interactions of HIV-1 reverse transcriptase: implication of central and C-terminal regions in subunit binding | Q43867754 | ||
| Interface peptides as structure-based human immunodeficiency virus reverse transcriptase inhibitors | Q45790255 | ||
| Rational drug design and HIV: Hopes and limitations | Q54171903 | ||
| RNase H activity of HIV reverse transcriptases is confined exclusively to the dimeric forms | Q59663057 | ||
| Disulfide linkage to polyacrylic resin for automated Fmoc peptide synthesis. Immunochemical applications of peptide resins and mercaptoamide peptides | Q72921588 | ||
| P433 | issue | 35 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 24941-6 | |
| P577 | publication date | 1999-08-27 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | A new potent HIV-1 reverse transcriptase inhibitor. A synthetic peptide derived from the interface subunit domains | |
| P478 | volume | 274 |
| Q46295068 | A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility |
| Q31072487 | A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase |
| Q42823248 | A peptide carrier for the delivery of biologically active proteins into mammalian cells. |
| Q38208847 | Allosteric modulation of protein oligomerization: an emerging approach to drug design |
| Q33935269 | Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells |
| Q35769639 | Analysis of mutations and suppressors affecting interactions between the subunits of the HIV type 1 reverse transcriptase |
| Q28201070 | Association of CIB with GPIIb/IIIa during outside-in signaling is required for platelet spreading on fibrinogen |
| Q24291845 | C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival |
| Q35070102 | Combining genetic and biochemical approaches to identify functional molecular contact points |
| Q39616052 | Comparison of electroporation and Chariot™ for delivery of β-galactosidase into mammalian cells: strategies to use trehalose in cell preservation |
| Q38364115 | Computer applications for prediction of protein-protein interactions and rational drug design. |
| Q55317261 | Development of peptide inhibitors of HIV transmission. |
| Q47576341 | Docking, molecular dynamics and quantitative structure-activity relationship studies for HEPTs and DABOs as HIV-1 reverse transcriptase inhibitors |
| Q28909786 | ERK1/2 regulates intracellular ATP levels through alpha-enolase expression in cardiomyocytes exposed to ischemic hypoxia and reoxygenation |
| Q36826400 | Effective protein inhibition in intact mouse oocytes through peptide nanoparticle-mediated antibody transfection |
| Q73569162 | Factors affecting the dimerization of the p66 form of HIV-1 reverse transcriptase |
| Q41500267 | Homodimerization of the p51 subunit of HIV-1 reverse transcriptase. |
| Q35917530 | Inhibition of HIV-1 reverse transcription: basic principles of drug action and resistance |
| Q34574076 | Integrating computational modeling and functional assays to decipher the structure-function relationship of influenza virus PB1 protein |
| Q57721879 | Interface Peptides |
| Q33347477 | Metabolic cleavage and translocation efficiency of selected cell penetrating peptides: a comparative study with epithelial cell cultures |
| Q34976859 | Modulation of the oligomeric structures of HIV-1 retroviral enzymes by synthetic peptides and small molecules |
| Q30329498 | Molecular modelling in structural biology. |
| Q43774982 | Oligomeric interaction of hepatitis C virus NS5B is critical for catalytic activity of RNA-dependent RNA polymerase |
| Q34747522 | Protein-protein interactions as targets for antiviral chemotherapy |
| Q38358165 | Role of residues in the tryptophan repeat motif for HIV-1 reverse transcriptase dimerization |
| Q34438247 | Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo. |
| Q37928913 | Targeting human immunodeficiency virus type 1 assembly, maturation and budding. |
| Q37820252 | Targeting the protein-protein interactions of the HIV lifecycle |
| Q33496608 | Transduction of the MPG-tagged fusion protein into mammalian cells and oocytes depends on amiloride-sensitive endocytic pathway |
| Q40761812 | Two independent regions of human telomerase reverse transcriptase are important for its oligomerization and telomerase activity |
| Q28213012 | c-Src-dependent transcriptional activation of TFII-I |
Search more.